Literature DB >> 28620901

Point/Counterpoint: Primary Debulking Surgery vs Neoadjuvant Chemotherapy for Newly Diagnosed Advanced Ovarian Cancer.

Renee A Cowan, Dennis S Chi, Anna Fagotti, Giovanni Scambia.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28620901

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN： 0890-9091            Impact factor:   2.990


× No keyword cloud information.
  4 in total

1.  Ovarian cancer initially presenting with supra-clavicular lymph node metastasis: A case report.

Authors:  Lu Hong; Hui Qiu; Zijie Mei; Hui Zhang; Shaopin Liu; Hong Cao
Journal:  Oncol Lett       Date:  2018-05-08       Impact factor: 2.967

2.  Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer.

Authors:  Sarah L Coleridge; Andrew Bryant; Sean Kehoe; Jo Morrison
Journal:  Cochrane Database Syst Rev       Date:  2021-02-05

3.  Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer.

Authors:  Sarah L Coleridge; Andrew Bryant; Thomas J Lyons; Richard J Goodall; Sean Kehoe; Jo Morrison
Journal:  Cochrane Database Syst Rev       Date:  2019-10-31

4.  Neoadjuvant chemotherapy before surgery versus surgery followed by chemotherapy for initial treatment in advanced ovarian epithelial cancer.

Authors:  Sarah L Coleridge; Andrew Bryant; Sean Kehoe; Jo Morrison
Journal:  Cochrane Database Syst Rev       Date:  2021-07-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.